Indeed, ketamine treatment negatively affected lncPVT1 levels, leading to ferroptosis onset in liver cancer cells and proving the potential benefits of targeting lncPVT1/miR-214-3p/GPX4 axis as novel therapeutic approach. Here, GPX4 is linked to liver cancer.